Journal of Isfahan Medical School

Journal of Isfahan Medical School

The Effect of Laser Diode MicroPulse Laser in Patients with Acute Central Serous Retinopathy in Comparison with Control Group: A Clinical Trial Study

Document Type : Original Article (s)

Authors
Heshmatollah Ghanbari 1
Omid Pirhaji 2
Mohamadreza Akhlaghi 1
1 Associate Professor, Department of Ophthalmology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Resident, Department of Ophthalmology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
10.22122/jims.v37i524.11424
Abstract
Background: The aim of this study was to determine the effectiveness of diode MicroPulse laser for improving visual acuity in patients with acute central serous retinopathy.Methods: In this clinical trial study, 26 patients with acute central serous retinopathy were selected and divided into two groups of 13; the first group was treated with diode MicroPulse laser; and in the second group, no intervention was performed. Patients in both groups were followed for three months, and visual acuity and recovery were compared between the two groups.Findings: The visual acuity (logMAR) before the start of treatment and at the 4th and 12th week of treatment did not show a significant difference between the two groups. In intragroup examination, visual acuity (logMAR) in both groups was significantly different (P < 0.01), but there was no significant difference between the two groups in the intergroup analysis (P = 0.82).Conclusion: Although the results of this study indicate that diode MicroPulse laser improves clinical and anatomical results in patients with acute central serous retinopathy, there is no statistically significant difference compared with spontaneous improvement of these patients.
Keywords
Central Serous Chorioretinopathy
Lasers
Visual acuity
  1. Brodie FL, Charlson ES, Aleman TS, Salvo RT, Gewaily DY, Lau MK, et al. Obstructive sleep apnea and central serous chorioretinopathy. Retina 2015; 35(2): 238-43.
  2. Schellevis RL, Breukink MB, Gilissen C, Boon CJF, Hoyng CB, de Jong EK, et al. Exome sequencing in patients with chronic central serous chorioretinopathy. Sci Rep 2019; 9(1): 6598.
  3. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 2008; 115(1): 169-73.
  4. Zhou M, Bakri SJ, Pershing S. Risk factors for incident central serous retinopathy: case-control analysis of a US national managed care population. Br J Ophthalmol 2019. [Epub ahead of print].
  5. Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol 2019; 103(6): 725-9.
  6. Lin J, Chen RWS. Central serous chorioretinopathy. In: Medina CA, Townsend JH, Singh AD, editors. Manual of retinal diseases: A guide to diagnosis and management. Cham, Switzerland: Springer International Publishing; 2016. p. 421-6.
  7. Bae K, Nam SW, Kang SW, Kim ES, Yu SY, Kim KT, et al. Central serous chorioretinopathy in elderly subjects: Angiographic and tomographic characteristics. Graefes Arch Clin Exp Ophthalmol 2019; 257(2): 279-88.
  8. Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol 2015; 160(3): 581-7.
  9. Ferrara D, Mohler KJ, Waheed N, Adhi M, Liu JJ, Grulkowski I, et al. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 2014; 121(3): 719-26.
  10. Breukink MB, Dingemans AJ, den Hollander AI, Keunen JE, MacLaren RE, Fauser S, et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol 2017; 11: 39-46.
  11. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 2001; 79(4): 417-21.
  12. Loo RH, Scott IU, Flynn HW, Jr., Gass JD, Murray TG, Lewis ML, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22(1): 19-24.
  13. Ooto S, Hangai M, Sakamoto A, Tsujikawa A, Yamashiro K, Ojima Y, et al. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy. Ophthalmology 2010; 117(9): 1800-9, 1809.
  14. Quin G, Liew G, Ho IV, Gillies M, Fraser-Bell S. Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 2013; 41(2): 187-200.
  15. Gallego-Pinazo R, Dolz-Marco R, Yzer S, Martinez-Ciriano J. Conventional Laser Treatment in CSC. In: Chhablani J, editor. Central Serous Chorioretinopathy. Cambridge, MA: Academic Press; 2019. p. 251-8.
  16. Behnia M, Khabazkhoob M, Aliakbari S, Abadi AE, Hashemi H, Pourvahidi P. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy. Retina 2013; 33(2): 324-8.
  17. Sharma T, Shah N, Rao M, Gopal L, Shanmugam MP, Gopalakrishnan M, et al. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 2004; 111(9): 1708-14.
  18. Lee CS, Kang EC, Lee KS, Byeon SH, Koh HJ, Lee SC. Central serous chorioretinopathy after renal transplantation. Retina 2011; 31(9): 1896-903.
  19. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95(4): 457-66.
  20. Sahoo P, Sahu A. Management of central serous chorioretinopathy (CSR) in Ayurveda-a case study. World J Pharm Res 2019; 8(6): 1424-33.
  21. Zhou L, Chong V, Lai K, Huang C, Xu F, Gong Y, et al. A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy. Lasers Med Sci 2019. [Epub ahead of print].
  22. Putnam CM, Vang SS. Modified photodynamic therapy treatment of central serous chorioretinopathy. Optom Vis Sci 2016; 93(7): 760-71.
  23. Cardillo PF, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23(6): 752-63.
  24. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 2008; 115(10): 1756-65.
  25. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010; 149(3): 441-6.
  26. Verma L, Sinha R, Venkatesh P, Tewari HK. Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]. BMC Ophthalmol 2004; 4: 15.
Journal of Isfahan Medical School
Volume 37, Issue 524 - Serial Number 524
March and April 2019
Pages 412-418

  • Receive Date 01 March 2019
  • Accept Date 06 April 2022